Deals & Capital Markets
Royalty Pharma Bets $500M on Teva's Vitiligo Antibody, Targeting Market With Only One Approved Drug
3d ago
You're signed outSign in or to get full access.
Leadership at TEVA PHARMACEUTICAL INDUSTRIES
Browse executives, board members, and key leadership.
Executives at TEVA PHARMACEUTICAL INDUSTRIES
Richard D. Francis
President and Chief Executive Officer
CEO
Executive
Board
Chris Fox
Executive Vice President, North America Commercial
Executive
David McAvoy
Executive Vice President, Chief Legal Officer
Executive
Eli Kalif
Executive Vice President, Chief Financial Officer
Executive
Eric Hughes
Executive Vice President, Global R&D and Chief Medical Officer
Executive
Evan Lippman
Executive Vice President, Business Development
Executive
Mark Sabag
Executive Vice President, International Markets Commercial
Executive
Matthew Shields
Executive Vice President, Teva Global Operations
Executive
Placid Jover
Executive Vice President, Chief Human Resources Officer
Executive
Richard Daniell
Executive Vice President, European Commercial
Executive
Board Members at TEVA PHARMACEUTICAL INDUSTRIES
Amir Elstein
Director
Board
Chen Lichtenstein
Director
Board
Gerald M. Lieberman
Director
Board
Janet S. Vergis
Director
Board
Perry D. Nisen
Director
Board
Roberto A. Mignone
Director
Board
Ronit Satchi-Fainaro
Director
Board
Rosemary A. Crane
Director
Board
Sol J. Barer
Chairman of the Board
Board
Tal Zaks
Director
Board
Varda Shalev
Director
Board